New study finds coffee — even decaf — reshapes gut microbes and may lift mood, cut stress and sharpen thinking
New research from APC Microbiome Ireland at University College Cork shows habitual moderate coffee intake (3–5 cups daily) reshapes the gut microbiome and is tied to improved mood, lower stress and changes in cognition via the gut‑brain axis.
- Habitual moderate coffee (3–5 cups/day) altered gut microbe communities and metabolites, links to lower stress, less depression and improved cognition — many effects occurred with both caffeinated and decaffeinated coffee (APC Microbiome Ireland / University College Cork news release).
- Study design: 62 adults (31 habitual coffee drinkers, 31 non‑drinkers) with abstinence and blind reintroduction phases; samples, diaries and metabolite profiling informed results (News‑Medical summary, UCC release).
- Caffeine-specific patterns: caffeinated coffee linked to reduced anxiety and better attention; decaf showed improvements in learning and episodic memory — suggesting non‑caffeine compounds also matter (UCC release).
- Limitations: small sample, self‑reported diaries, incomplete control over additives, and sponsorship by the Institute for Scientific Information on Coffee (ISIC) warrant cautious interpretation (Ground.News overview).
Study details and citation
Study: “Habitual coffee intake shapes the gut microbiome and modifies host physiology and cognition.” Boscaini, S., et al., Nature Communications, 2026. DOI: 10.1038/s41467-026-71264-8. Reporting and summaries are available from the News‑Medical summary and the APC Microbiome Ireland / University College Cork news release.
Methods and study design
The research followed 62 volunteers — 31 habitual coffee drinkers (defined as 3–5 cups daily) and 31 non‑drinkers. Investigators collected psychological tests, food and caffeine diaries, stool and urine samples, and metabolite profiles. Drinkers stopped coffee for two weeks (abstinence phase), during which gut metabolite profiles shifted compared with non‑drinkers. Coffee was then reintroduced in a blinded test: participants received either caffeinated or decaffeinated coffee without knowing which type they were drinking (UCC release, News‑Medical).
What the researchers found about microbes
Habitual coffee intake was associated with higher levels of bacteria the authors describe as “beneficial”. Notable increases included Eggerthella species and Cryptobacterium curtum. These microbes are linked to gastric and intestinal acid secretion and steps in bile acid synthesis — processes that help eliminate harmful organisms and manage inflammation. The study also reported elevated Firmicutes in some coffee drinkers, a group previously associated with positive emotions in women. Overall, coffee appears to change how the gut microbial community uses metabolites, potentially supporting longer‑term gut health (UCC release).
Effects on mood, stress and cognition
Across participants, both caffeinated and decaffeinated coffee were associated with lower self‑reported perceived stress, depression and impulsivity compared with the abstinence period, suggesting non‑caffeine components (for example, polyphenols and antioxidants) play a major role.
Caffeine‑specific findings:
- Caffeinated coffee: linked to reduced anxiety, improved attention and vigilance, and signs of reduced inflammation risk (UCC release).
- Decaffeinated coffee: associated with significant improvements in learning and episodic memory; investigators suggested improved sleep quality and increased activity among decaf drinkers might explain these gains.
Researcher perspective
“Coffee is more than just caffeine — it’s a complex dietary factor that interacts with our gut microbes, our metabolism, and even our emotional wellbeing,” said Professor John Cryan, principal investigator at APC Microbiome Ireland (UCC release).
Limitations and potential conflicts
The authors caution against overclaiming: the study relied heavily on self‑reported diaries (introducing recall and subjective bias), did not fully control for common coffee additives (sugar, dairy) that affect microbes and mood, and had a small sample size (62 people). The research was sponsored by the Institute for Scientific Information on Coffee (ISIC), a disclosed fact readers should weigh when assessing potential industry influence (Ground.News overview, UCC release).
How the findings fit with other science
This study strengthens evidence linking diet, gut microbes and the gut‑brain axis. Coffee—containing hundreds of bioactive compounds beyond caffeine such as polyphenols and antioxidants—can shape microbial communities and the metabolites they produce, which in turn may affect mood and cognition (News‑Medical).
Implications for California
Economic and lifestyle relevance: California’s vibrant coffee culture — from neighborhood cafés to specialty roasters — could see consumer interest in coffee gut‑health messaging. Roasters and cafés might promote decaf and low‑acid methods to appeal to customers seeking cognitive and mood benefits without caffeine’s sleep or anxiety effects.
Public health and clinical practice: Clinicians and public‑health officials could consider dietary patterns, including moderate coffee (3–5 cups daily), as one of many low‑cost lifestyle strategies to support mental wellbeing. Recommendations must be individualized for pregnancy, heart disease, sleep disorders and caffeine sensitivities.
Work and productivity: Employers and wellness programs might reassess coffee‑breaks and quality decaf options as part of staff wellbeing strategies; decaf may support learning and memory where sleep is a priority (UCC release).
Consumer questions: Californians should consider preparation: sugar, flavored syrups and high‑fat dairy add calories and can alter gut effects. The study used moderate portions (3–5 cups/day); people with medical concerns should consult clinicians before changing intake.
Where to read the study and related coverage
Conclusion
Bottom line: The study adds evidence that coffee is a complex dietary factor that interacts with gut microbes and the central nervous system via the gut‑brain axis. While findings are promising for mood, stress and cognition, larger controlled trials that limit confounding additives and examine long‑term effects are needed before firm public‑health guidance can be issued.
